Literature DB >> 11368385

Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloid leukemia.

M Svaldi, A Lanthaler, R Venturi, P Coser, M Mitterer.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11368385     DOI： 10.1038/sj.leu.2402082

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2).

Authors:  Daniel Bustamante; Kathryn R Chan; David R Czuchlewski; A Amir Al Saadi
Journal:  Int J Hematol       Date:  2012-02-25       Impact factor: 2.490

2.  p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).

Authors:  Hai-ping Dai; Yong-quan Xue; Li-li Wu; Jin-lan Pan; Yan-lei Gong; Ya-fang Wu; Jun Zhang; De-pei Wu; Su-ning Chen
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

3.  t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.

Authors:  Candida Vitale; Xinyan Lu; Balkees Abderrahman; Koichi Takahashi; Farhad Ravandi; Elias Jabbour
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

4.  Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.

Authors:  Eunhee Han; Hyeyoung Lee; Myungshin Kim; Yonggoo Kim; Kyungja Han; Sung-Eun Lee; Hee-Je Kim; Dong-Wook Kim
Journal:  Blood Res       Date:  2014-03-24

5.  De Novo Acute Myeloid Leukemia with Combined CBFB-MYH11 and BCR-ABL1 Gene Rearrangements: A Case Report and Review of Literature.

Authors:  Venkata Rakesh Sethapati; Ra'ed Jabr; Leyla Shune; Wissam El Atrouni; Patrick R Gonzales; Wei Cui; Shivani Golem
Journal:  Case Rep Hematol       Date:  2020-12-16

6.  Coexistence of p210BCR-ABL and CBFβ-MYH11 fusion genes in myeloid leukemia: A report of 4 cases.

Authors:  Yuan-Yuan Wang; Wen-Jing Ding; Feng Jiang; Zi-Xing Chen; Jian-Nong Cen; Xiao-Fei Qi; Jian-Ying Liang; Dan-Dan Liu; Jin-Lan Pan; Su-Ning Chen
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.